Covid negatif mungkin punca jangkitan
How false negatives are complicating COVID-19
testing
April 11, 2020
WASHINGTON, United States — As COVID-19 tests become more widely
available across the US, scientists have warned about a growing concern: Many
people with negative results might actually have the virus.
That could have devastating implications as a global recession
looms and governments wrangle with the question of when to reopen economies
shuttered as billions of people were ordered to stay home in an effort to break
transmission of the deadly disease.
The majority of tests around the world use a technology called
PCR, which detects pieces of the
coronavirus in mucus samples.
But "there are a lot of things that impact whether or not
the test actually picks up the virus," Priya Sampathkumar, an infectious
diseases specialist at Mayo Clinic in Minnesota, told AFP.
"It depends on how much virus the person is shedding
(through sneezing, coughing and other bodily functions), how the test was
collected and whether it was done appropriately by someone used to collecting
these swabs, and then how long it sat in transport," she said.
The virus has only been spreading among humans for four months
and therefore studies about test reliability are still considered preliminary.
Early reports from China suggest its sensitivity, meaning how
well it is able to return positive results when the virus is present, is
somewhere around 60 to 70 percent.
Different companies around the world are now producing slightly
different tests, so it's hard to have a precise overall figure.
But even if it were possible to increase the sensitivity to 90
percent, the magnitude of risk remains substantial as the number of people
tested grows, Sampathkumar argued in a paper published in Mayo Clinic
Proceedings.
"In California, estimates say the rate of COVID-19
infection may exceed 50 percent by mid-May 2020," she said.
With 40 million people, "even if only one percent of the
population was tested, 20,000 false-negative results would be
expected."
This makes it critical for clinicians to base their diagnosis on
more than just the test: they must also examine a patient's symptoms, their
potential exposure history, imaging and other lab work.
Timing is everything
Part of the problem lies in locating the virus as its area of
highest concentration shifts within the body.
The main nasal swab tests examine the nasopharynx, where the
back of the nose meets the top of the throat. This requires a trained hand to
perform and some portion of the false negatives arises from improper procedure.
But even if done correctly, the swab may produce a false
negative. That's because as the disease progresses, the virus passes from the
upper to the lower respiratory system.
In these cases, the patient may be asked to try to cough up
sputum -- mucus from the lower lungs -- or doctors may need to take a sample
more invasively, when a patient is under sedation.
Daniel Brenner, an emergency physician at Johns Hopkins Hospital
in Baltimore, described to AFP taking a test after performing a procedure
called a bronchoalveolar lavage.
This was done on a patient whose nasal swab returned negative
three times, but who showed all the signs of COVID-19.
Eventually, the patient's medical team placed a camera down his
windpipe to examine the lungs, then sprayed fluid in and sucked out the
secretions, which were then tested, resulting in a positive.
No perfect test
Uncertainty in clinical diagnoses is not new, and clinicians are
well aware that no type of test for any condition can be considered perfect.
What makes COVID-19 different is its newness, said Sampathkumar.
"Most of the time when you have tests, you have test
characteristics outlined carefully and warnings about tests
interpretation," she said.
"We had no test for so long, and when we got the test, we
started using it widely and sort of forgot the basics."
After being slow to start mass testing, the US has ramped up
production and has tested almost 2.5 million people, with pharmacists now
authorized to carry out the procedure.
But "the real fear of that is people who are given a false
negative test and then decide that they're safe to go around their daily life
and go out and expose people," said Brenner.
Much hope is placed on newly available serological tests which
look for antibodies produced by a person's body in response to the virus and
can tell whether a person was infected, long after they recovered.
They could also be used to help diagnose a person who is
currently infected but whose PCR test results showed a false negative, by
waiting a week or so for the body to produce its immune response.
"We are excited about the serologic test, but we don't know
how well it will work and we are starting to study it," said Sampathkumar.
.
No comments:
Post a Comment
Note: only a member of this blog may post a comment.